Treatment- Directly Observed Therapy (DOT)

This report explains the European DOTS Expansion plan to control TB. The plan highlights country needs and resource gaps, emphasizing collaboration with the governments of endemic countries, national and international agencies, and nongovernmental organizations (NGOs). The aim is to stimulate social and political commitment to achieving the global TB targets as part of the overall health system. The plan is based on two principles: the development of national DOTS expansion plans and partnership-building to control TB.

This pocket-size drug treatment information card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in adults, including dosages, daily and intermittent regimens, side effects, treatment information, and visual depictions of first-line medications.

This guide provides information about TB treatment for TB supporters who ensure that patients take their TB drugs regularly and on schedule for the full duration of the treatment.

This report assesses the effectiveness, cost, and cost-effectiveness of the public-private mix DOTS (PPM-DOTS) program in pilot projects in Hyderabad and Delhi, India.

This report provides suggestions that may facilitate increased involvement of the National Tuberculosis Control Program (NTP) in health sector reform, encourage increased technical input into health systems' planning, and promote the strategic positioning of TB control in the context of changing health systems.

This report presents a tools package for public-private mix initiatives for DOTS implementation (PPM-DOTS) as a means of TB control. The purpose is to help national TB program (NTP) managers begin involving private providers (PPs) in DOTS implementation and to sustain collaboration.

This report discusses the economic, psychological, and social impacts of TB and the strategies that households use to cope with them.

This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.

This film's primary focus is on DOTS in Rajasthan, India and on TB/HIV in Malawi, with scientific commentary provided by Dr. Douglas Young, chairman of the Stop TB Working Group on New Vaccines. A sub-theme running throughout the film is the urgent need for new tools -- drugs, diagnostics and vaccines -- in order to turn the tide against the epidemic.

This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB in DOTS-Plus projects.